Cells for ribosomal fractionation were incubated with cycloheximide (100 µg/ml) for 15 min.
They were then harvested and resuspended in HMK lysis buffer (25 mM HEPES-OH pH 7.5, 5 mM MgCl 2 , 100 mM KCl, 1 % Triton X-100, 2 mM DTT, 50 units/ml RNasin and protease inhibitors) at 4°C. The suspension was then passed twelve times through a 25-gauge needle with syringe. Cell lysates were centrifuged at 15,000 × g at 4 °C for 10 min. Supernatants were collected and loaded on 10 ~ 50 % (w/v) linear sucrose gradient (20 mM Tris-Cl pH 7.5, 150 mM NaCl, and 2.5 mM MgCl 2 ). Each ribosomal profile was monitored and fractionated by measuring absorbance at 254 nm using a Duo-Flow system (Bio-Red). For ribosomal pelleting, the supernatant was layered over a sucrose cushion (20 % w/v) followed by centrifugation at 32,000 rpm for 3h at 4°C in a Beckman SW41Ti rotor. Next, the ribosome pellet was solubilized with resuspendend buffer (10 mM Tris-HCl pH 7.5, 2 % SDS and 150 mM NaCl) containing 2 mM sodium orthovanadate and 50 mM sodium fluoride.
Western Blotting and immunoprecipitation
Cells were lysed in lysis buffer (50 mM Tris-Cl, pH 7.4, 150mM NaCl, 0.5 % NP-40, 0.25 % sodium deoxycholate and protease inhibitors) and cleared by centrifugation. Proteins from total cell lysates or immunoprecipitates were separated by SDS-PAGE and transferred onto PVDF membrane (Bio-Rad). For immunoprecipitation of ribosomal pellets with antiubiquitin antibody, the resuspensions of ribosomal pellets were boiled and sonicated followed by dilution with ten volumes of dilution buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA and 1 % Triton X-100). Western blotting was performed using chemiluminescence blotting substrate (Boehringer Mannheim). Horseradish peroxidaseconjugated anti-mouse IgG and anti-rabbit IgG (Boehringer Mannheim) were used as secondary antibodies.
Nuclei Fractionation
For subcellular fractionation, cells were harvested, washed with PBS, and resuspended in buffer I (10 mM Hepes pH 7.9, 10 mM NaCl, 0.1 mM EDTA, 1 mM DTT and protease inhibitors). After incubation on ice for 15 min, plasma membranes were disrupted by the addition of 0.3 % Nonidet P-40 followed by mixing for 10 secs. The nuclei were pelleted by centrifugation at 13,000 rpm for 1 min and the cytoplasmic fraction (supernatant) was discarded. After washing three times, the pellets were resuspended in buffer II (20 mM Hepes pH 7.9, 0.5 mM EDTA, 0.5 mM EGTA, 0.4 M NaCl, 1 mM DTT, and protease inhibitors), rocked for 30 mins on ice, and centrifuged at 3000 × g for 15 mins at 4
°C to recover the nuclear fraction.
Proteomics of RPS3
RPS3 was purified from solubilized ribosome pellet by immunoprecipitation using anti-RPS3
antibody. Gel bands were excised and destained with 25 mM NH 4 HCO 3 in 50 % acetonitrile.
Proteins in bands were reduced with 10 mM DTT in 25 mM NH 4 HCO 3 at 56 °C for 1 h and alkylated with 55 mM iodoacetamide at 25 °C for 1 h in the dark. Gel slices were washed with 25 mM NH 4 HCO 3 in 50% acetonitrile followed by soaking in a chilled 25 mM NH 4 HCO 3 solution containing 12 ng/µl of sequencing grade trypsin (Promega, USA) for 45 min. After removing residual trypsin, gel slices were incubated at 37 °C for 16 h. Digested peptides were extracted sequentially with 25 mM NH 4 HCO 3 in 50 % acetonitrile, 0.25 % TFA in 50 % acetonitrile, and 0.25 % TFA in 70 % acetonitrile. These three extracts were pooled and dried using a vacuum evaporator.
Mass spectrometric analyses were performed using a linear ion trap mass spectrometer (LTQ, Thermo Electron, USA) connected with an Agilent nanoflow-1200 HPLC system. The dried Each strain grown to early log phage was treated with or without 200 µg/ml of CHX for the indicated times. Cell extracts were analyzed by immunoblot with indicated antibodies. "L"
and "S" indicates long exposure and short exposure, respectively. (A) HT1080 cells treated with rapamycin or emetine were incubated for 2 h. Cell lysates were subjected to immunoblot analysis using the indicated antibodies. (B) HT1080 cells were treated with 10 μM NSC119889 for the indicated times and cell lysates were subjected to immunoblot analysis using the indicated antibodies.
Fig S5.
Mono-ubiquitination of Rps3p induced by rapamycin disappears in ufd3∆ strain.
Wild-type (wt) and ufd3∆ strains were grown to early log phase in YPD media, treated with rapamycin (100 ng/ml), and incubated for 1 h. Whole cell lysates were analyzed by immunoblot with anti-Rps3p, eIF2a~p, and Pgk1p antibodies.
Fig S6.
Mono-ubiquitination of RPS3 is not induced by DNA damaging agents.
HT1080 cells were treated with 10 μM ara-C or 10 μM camptothecin for the indicated times and cell lysates were subjected to immunoblot analysis using the indicated antibodies. 
